
Opinion|Videos|January 31, 2025
Latest Trends and Innovations in CLL and MCL Treatment
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
3
Contributor: Why Public Health Keeps Failing—and How to Fix It
4
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
5